Senate Bill S984

2019-2020 Legislative Session

Relates to dihydropyrimidine dehydrogenase deficiency testing

download bill text pdf

Sponsored By

Archive: Last Bill Status - In Senate Committee Health Committee


  • Introduced
    • In Committee Assembly
    • In Committee Senate
    • On Floor Calendar Assembly
    • On Floor Calendar Senate
    • Passed Assembly
    • Passed Senate
  • Delivered to Governor
  • Signed By Governor

Do you support this bill?

Please enter your contact information

Home address is used to determine the senate district in which you reside. Your support or opposition to this bill is then shared immediately with the senator who represents you.

Optional services from the NY State Senate:

Create an account. An account allows you to officially support or oppose key legislation, sign petitions with a single click, and follow issues, committees, and bills that matter to you. When you create an account, you agree to this platform's terms of participation.

Include a custom message for your Senator? (Optional)

Enter a message to your senator. Many New Yorkers use this to share the reasoning behind their support or opposition to the bill. Others might share a personal anecdote about how the bill would affect them or people they care about.
Actions
Votes

2019-S984 (ACTIVE) - Details

See Assembly Version of this Bill:
A7533
Current Committee:
Senate Health
Law Section:
Public Health Law
Laws Affected:
Add §2400-a, Pub Health L; amd §§3216, 3221 & 4303, Ins L; add §365-o, Soc Serv L
Versions Introduced in Other Legislative Sessions:
2017-2018: S7710, A11279
2021-2022: S1462, A3191

2019-S984 (ACTIVE) - Summary

Requires dihydropyrimidine dehydrogenase deficiency testing prior to fluoropyrmidine or other antimetabolite treatment; requires policies and contracts of insurance to include coverage for dihydropyrimidine dehydrogenase deficiency testing; provides for dihydropyrimidine dehydrogenase deficiency testing under the medical assistance program.

2019-S984 (ACTIVE) - Sponsor Memo

2019-S984 (ACTIVE) - Bill Text download pdf

                            
 
                     S T A T E   O F   N E W   Y O R K
 ________________________________________________________________________
 
                                    984
 
                        2019-2020 Regular Sessions
 
                             I N  S E N A T E
 
                              January 9, 2019
                                ___________
 
 Introduced  by  Sen. BRESLIN -- read twice and ordered printed, and when
   printed to be committed to the Committee on Health
 
 AN ACT to amend the public health law, in relation to requiring dihydro-
   pyrimidine dehydrogenase deficiency testing  for  certain  individuals
   with  cancer;  to  amend  the  insurance law, in relation to requiring
   policies and contracts of insurance to include coverage for dihydropy-
   rimidine dehydrogenase deficiency testing; and  to  amend  the  social
   services law, in relation to the provision of dihydropyrimidine dehyd-
   rogenase deficiency testing under the medical assistance program
 
   THE  PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND ASSEM-
 BLY, DO ENACT AS FOLLOWS:
 
   Section 1. The public health law is amended by adding  a  new  section
 2400-a to read as follows:
   §  2400-A.  DIHYDROPYRIMIDINE DEHYDROGENASE DEFICIENCY TESTING. 1. FOR
 PURPOSES OF THIS SECTION THE FOLLOWING TERMS SHALL  HAVE  THE  FOLLOWING
 MEANINGS:
   (A)  "ANTIMETABOLITES"  MEANS  A  SUBSTANCE  THAT  INTERFERES WITH THE
 NORMAL METABOLIC PROCESSES WITHIN CELLS,  TYPICALLY  BY  COMBINING  WITH
 ENZYMES.
   (B)  "DIHYDROPYRIMIDINE DEHYDROGENASE DEFICIENCY" MEANS A CONDITION IN
 WHICH THE BODY CANNOT BREAK DOWN THE NUCLEOTIDES THYMINE AND URACIL.
   (C) "FLUOROPYRMIDINE" MEANS A GROUP OF SUBSTANCES USED TO TREAT CANCER
 THROUGH CHEMOTHERAPY.
   2. EVERY PHYSICIAN OR OTHER AUTHORIZED PRACTITIONER WHO PROVIDES FLUO-
 ROPYRMIDINE OR  OTHER  ANTIMETABOLITES  TO  INDIVIDUALS  DIAGNOSED  WITH
 CANCER  SHALL  TEST FOR DIHYDROPYRIMIDINE DEHYDROGENASE DEFICIENCY PRIOR
 TO SUCH TREATMENT.
   § 2. Subparagraph (A) of paragraph 12-a of subsection (i)  of  section
 3216 of the insurance law, as amended by chapter 12 of the laws of 2012,
 is amended to read as follows:
 
  EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets
                       [ ] is old law to be omitted.
                                                            LBD02330-01-9
              

Comments

Open Legislation is a forum for New York State legislation. All comments are subject to review and community moderation is encouraged.

Comments deemed off-topic, commercial, campaign-related, self-promotional; or that contain profanity, hate or toxic speech; or that link to sites outside of the nysenate.gov domain are not permitted, and will not be published. Attempts to intimidate and silence contributors or deliberately deceive the public, including excessive or extraneous posting/posts, or coordinated activity, are prohibited and may result in the temporary or permanent banning of the user. Comment moderation is generally performed Monday through Friday. By contributing or voting you agree to the Terms of Participation and verify you are over 13.

Create an account. An account allows you to sign petitions with a single click, officially support or oppose key legislation, and follow issues, committees, and bills that matter to you. When you create an account, you agree to this platform's terms of participation.